287 participants
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-08
- Start Date:
- 2024-04-22
- Completion:
- 2027-12-27
Conditions
- Squamous Cell Carcinoma of Head and Neck
Interventions
- BIOLOGICAL
- DRUG
No Results Yet